IN Brief:
- Sensory research suggests GLP-1 users may experience sweetness and bitterness differently from other consumers.
- Artificial sweeteners may be more noticeable where bitter off-notes are detected more sensitively.
- The trend adds another reformulation pressure for manufacturers balancing sugar reduction, HFSS rules, and product experience.
MMR Research and Huxly sensory work is pointing to a more complicated future for sugar reduction, as GLP-1 users appear to perceive sweetness, bitterness, and artificial notes differently from the wider population.
The research suggests that GLP-1 drugs can alter sweetness perception and may make some users more sensitive to bitter off-notes associated with artificial sweeteners. That creates a formulation challenge for manufacturers using sweetener systems to reduce sugar, manage calories, meet HFSS thresholds, or respond to changing health expectations.
Artificial sweeteners rarely deliver only sweetness. Depending on the ingredient, matrix, concentration, and processing conditions, they can introduce delayed sweetness, lingering sweetness, metallic notes, bitterness, cooling effects, or flavour imbalance. Conventional reformulation often manages those effects through blends, flavours, masking systems, acids, bulking agents, fibres, texture work, and changes to aroma release.
GLP-1 use adds another variable. Appetite suppression can make each eating occasion more selective, while changing taste perception can alter how consumers respond to sweetness intensity and overall product quality. A product that works for one group may feel too artificial, too intense, too thin, or insufficiently satisfying for another.
The effects stretch across confectionery, bakery, drinks, dairy, desserts, snacks, and functional foods. Many of these categories rely on sweetness as part of texture, indulgence, aroma, mouthfeel, colour development, bulking, freezing point control, preservation, and processing behaviour. Removing sugar is therefore rarely a one-for-one ingredient swap.
Huxly’s Amy Benjamin has argued that GLP-1 users respond not only to sweetness intensity, but to the quality and cleanliness of sweetness. Cargill has also emphasised the full product experience, including texture, mouthfeel, aroma, and appearance. Reformulation programmes that focus narrowly on sugar reduction can miss the sensory architecture that makes a product commercially viable.
The shift lands in a regulatory environment already putting pressure on sweet foods and drinks. Compliance pressure around delayed UK energy drink restrictions has kept nutrition policy high on the agenda, while Pladis has extended McVitie’s Jaffa into soft-baked cookie formats, showing that indulgence-led categories continue to develop despite tighter health scrutiny.
GLP-1 growth may sharpen that tension. Users may eat less frequently, buy smaller portions, or prioritise products that feel more worthwhile. That could favour premiumisation, portion control, protein enrichment, fibre, texture-led formats, and more natural positioning, while weakening the appeal of products that rely heavily on artificial sweetener substitution.
Ingredient suppliers with technologies covering sweetness modulation, flavour masking, mouthfeel, and calorie reduction are likely to attract closer attention. The technical challenge is not simply to reduce sugar, but to rebuild sweetness, body, flavour release, and satisfaction in a way that survives both processing and consumer comparison.
The difficulty is especially acute in products where sugar contributes to structure. In biscuits, cakes, and confectionery, sugar affects aeration, spread, browning, crystallisation, viscosity, shelf life, and snap. In beverages, it influences body, flavour release, acidity balance, and perceived refreshment. In frozen desserts, it contributes to texture and freezing behaviour.
Manufacturers will need stronger sensory segmentation. A single reduced-sugar version may not cover the market if GLP-1 users, sugar reducers, mainstream consumers, children, older adults, and premium buyers respond differently to the same sweetener system. That increases the need for application-specific testing rather than desk-based reformulation.
Cost will also shape the pace of change. Sweetener systems, fibres, proteins, hydrocolloids, natural flavours, and masking technologies can increase ingredient complexity. Reformulation also brings production trials, shelf-life testing, allergen and label checks, packaging updates, and potential line adjustments.
The GLP-1 effect is still developing, and not every claim around the category will translate into mainstream food demand. Yet sugar reduction is moving from a regulatory exercise into a more nuanced sensory and behavioural challenge. Sweetness has to taste right, feel right, process correctly, and fit a more selective eating pattern. Artificial sweeteners remain important tools, but simple substitution is becoming harder to defend.
